NCT05334004 2026-04-22
Lopinavir/Ritonavir in PLWH With High-Grade AIN
University of Wisconsin, Madison
Phase 1 Recruiting
Clinical Trials
5 trialsNCT01165645 2022-12-01
Lopinavir and Ritonavir in Improving Immune Response to Vaccines in Patients With Complete Remission Following A Bone Marrow Transplant for Hodgkin Lymphoma
Mayo Clinic
Phase NA Withdrawn
NCT04455958 2021-04-26
Lopinavir/Ritonavir for the Treatment of COVID-19 Positive Patients With Cancer and Immune Suppression in the Last Year
OHSU Knight Cancer Institute
Phase 2 Withdrawn
NCT00444379 2014-08-20
ARKS
University of California, San Francisco
Phase 4 Completed
NCT01095094 2013-06-10
Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma
Case Comprehensive Cancer Center
Phase 2 Terminated